Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review

Author:

Edinoff Amber N.1,Armistead Grace1,Rosa Christina A2,Anderson Alexandra1,Patil Ronan3,Cornett Elyse M1,Murnane Kevin S.4,Kaye Adam M.5,Kaye Alan D.1

Affiliation:

1. Louisiana State University Health Shreveport

2. University of California, Santa Barbara

3. The George Washington University

4. Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Shreveport; Louisiana State University Health Shreveport, Department of Pharmacology, Toxicology & Neuroscience; Louisiana Addiction Research Center

5. Thomas J. Long School of Pharmacy, University of the Pacific, Stockton

Abstract

Phenothiazines, a diverse class of drugs, can be used to treat multiple mental health and physical conditions. Phenothiazines have been used for decades to treat mental illnesses, including schizophrenia, mania in bipolar disorder, and psychosis. Additionally, these drugs offer relief for physical illnesses, including migraines, hiccups, nausea, and vomiting in both adults and children. Further research is needed to prove the efficacy of phenothiazines in treating physical symptoms. Phenothiazines are dopaminergic antagonists that inhibit D2 receptors with varying potency. High potency phenothiazines such as perphenazine are used to treat various psychiatric conditions such as the positive symptoms of schizophrenia, the symptoms of psychosis, and mania that can occur with bipolar disorder. Low/mid potency phenothiazines such as chlorpromazine antipsychotic drugs that have been used to treat schizophrenia and schizophrenia-like disorders since the 1950s and are utilized in numerous disease states. The present investigation aims to elucidate the effects of phenothiazines in clinical practice.

Publisher

Open Medical Publishing

Reference48 articles.

1. Neuroleptics: Clinical Use in Psychiatry;John M. Davis,1978

2. Chlorpromazine versus placebo for schizophrenia;Clive E Adams;Cochrane Database of Systematic Reviews,2014

3. The Complete Drug Reference;W. Martindale,1999

4. Perphenazine (Trilafon) Treatment of Psychoses;P.O. O’Reilly;Can Med Assoc J,1957

5. Perphenazine for schizophrenia;Benno Hartung;Cochrane Database of Systematic Reviews,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3